CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
US Bahasa Indonesia
Negara • United States
    Entitas • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    Perdagangan Abbott Laboratories - ABT CFD

    103.67
    0.43%
    0.16
    Rendah: 103.33
    Tinggi: 104.58
    Market Trading Hours* (UTC) Opens on Tuesday at 13:30

    Mon - Fri: 13:30 - 20:00

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.16
    Biaya inap posisi Long

    Long position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight -0.025457 %
    Charges from borrowed part ($-1.02)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		-0.025457%
    Biaya inap posisi short

    Short position overnight fee

    Margin. Your investment $1,000.00
    Biaya Overnight 0.003235 %
    Charges from borrowed part ($0.13)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    Kunjungi platform
    		0.003235%
    Waktu biaya inap 21:00 (UTC)
    Kuantitas min. yang diperdagangkan 1
    Mata uang USD
    Margin 20%
    Bursa efek United States of America
    Komisi perdagangan 0%

    *Information provided by Capital.com

    Abbott Laboratories ESG Risk Ratings

    High Medium Low Negligible

    ‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

    Key Stats
    Prev. Close* 104.12
    Open* 104.19
    1-Year Change* -10.54%
    Day's Range* 103.33 - 104.58
    52 wk Range 93.25-118.23
    Average Volume (10 days) 5.06M
    Average Volume (3 months) 109.82M
    Market Cap 181.20B
    P/E Ratio 31.59
    Shares Outstanding 1.74B
    Revenue 41.51B
    EPS 3.30
    Dividend (Yield %) 1.95777
    Beta 0.66
    Next Earnings Date Jul 18, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Jun 2, 2023 104.12 1.18 1.15% 102.94 104.43 102.65
    Jun 1, 2023 102.71 1.41 1.39% 101.30 102.84 100.41
    May 31, 2023 101.89 0.79 0.78% 101.10 102.13 100.26
    May 30, 2023 101.62 -0.32 -0.31% 101.94 102.45 101.29
    May 26, 2023 102.79 0.80 0.78% 101.99 103.38 101.43
    May 25, 2023 102.04 -0.75 -0.73% 102.79 103.24 101.17
    May 24, 2023 103.95 -1.50 -1.42% 105.45 105.45 103.87
    May 23, 2023 105.62 -1.41 -1.32% 107.03 107.40 105.35
    May 22, 2023 108.13 0.15 0.14% 107.98 109.24 107.92
    May 19, 2023 108.81 0.93 0.86% 107.88 109.88 107.88
    May 18, 2023 108.40 0.38 0.35% 108.02 108.76 107.54
    May 17, 2023 108.69 -1.06 -0.97% 109.75 109.81 107.72
    May 16, 2023 109.28 0.52 0.48% 108.76 110.37 108.71
    May 15, 2023 109.72 -0.32 -0.29% 110.04 110.82 109.32
    May 12, 2023 110.36 1.14 1.04% 109.22 110.46 109.12
    May 11, 2023 109.92 -0.15 -0.14% 110.07 110.31 109.16
    May 10, 2023 110.60 0.42 0.38% 110.18 110.87 109.48
    May 9, 2023 110.17 0.71 0.65% 109.46 110.95 109.10
    May 8, 2023 110.78 0.42 0.38% 110.36 111.50 109.79
    May 5, 2023 111.15 0.45 0.41% 110.70 111.66 110.70

    Abbott Laboratories Events

    Time (UTC) Country Event
    Tuesday, July 18, 2023

    Time (UTC)

    12:30

    Country

    US

    Event

    Q2 2023 Abbott Laboratories Earnings Release
    Q2 2023 Abbott Laboratories Earnings Release

    Forecast

    -

    Previous

    -
    Tuesday, October 17, 2023

    Time (UTC)

    12:30

    Country

    US

    Event

    Q3 2023 Abbott Laboratories Earnings Release
    Q3 2023 Abbott Laboratories Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 43653 43075 34608 31904 30578
    Revenue 43653 43075 34608 31904 30578
    Cost of Revenue, Total 19083 18490 14967 13196 12691
    Gross Profit 24570 24585 19641 18708 17887
    Total Operating Expense 35336 34650 29136 27435 27095
    Selling/General/Admin. Expenses, Total 11109 11217 9676 9694 9691
    Research & Development 2741 2733 2403 2408 2288
    Depreciation / Amortization 2013 2047 2132 1936 2178
    Unusual Expense (Income) 390 163 -42 201 247
    Operating Income 8317 8425 5472 4469 3483
    Interest Income (Expense), Net Non-Operating -377 -491 -492 -583 -749
    Other, Net 366 277 -12 191 139
    Net Income Before Taxes 8306 8211 4968 4077 2873
    Net Income After Taxes 6933 7071 4497 3601 2464
    Net Income Before Extra. Items 6933 7071 4497 3601 2464
    Total Extraordinary Items 0 -2 86 -96
    Net Income 6933 7071 4495 3687 2368
    Income Available to Common Excl. Extra. Items 6933 7071 4497 3601 2464
    Income Available to Common Incl. Extra. Items 6933 7071 4495 3687 2368
    Diluted Net Income 6933 7071 4495 3687 2368
    Diluted Weighted Average Shares 1764 1789 1786 1781 1770
    Diluted EPS Excluding Extraordinary Items 3.93027 3.95249 2.51792 2.0219 1.39209
    Dividends per Share - Common Stock Primary Issue 1.88 1.8 1.44 1.28 1.12
    Diluted Normalized EPS 4.11623 4.03095 2.49663 2.12158 1.51177
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Total revenue 9747 10091 10410 11257 11895
    Revenue 9747 10091 10410 11257 11895
    Cost of Revenue, Total 4325 4593 4629 4933 4987
    Gross Profit 5422 5498 5781 6324 6908
    Total Operating Expense 8238 8787 8640 8881 8983
    Selling/General/Admin. Expenses, Total 2751 2973 2731 2757 2787
    Research & Development 654 725 671 684 697
    Depreciation / Amortization 491 496 498 507 512
    Unusual Expense (Income) 17 0 111
    Operating Income 1509 1304 1770 2376 2912
    Interest Income (Expense), Net Non-Operating -58 -52 -105 -106 -114
    Other, Net 111 68 93 82 78
    Net Income Before Taxes 1562 1320 1758 2352 2876
    Net Income After Taxes 1318 1033 1435 2018 2447
    Net Income Before Extra. Items 1318 1033 1435 2018 2447
    Total Extraordinary Items
    Net Income 1318 1033 1435 2018 2447
    Income Available to Common Excl. Extra. Items 1318 1033 1435 2018 2447
    Income Available to Common Incl. Extra. Items 1318 1033 1435 2018 2447
    Diluted Net Income 1318 1033 1435 2018 2447
    Diluted Weighted Average Shares 1751.71 1752.46 1763.65 1765.46 1774.54
    Diluted EPS Excluding Extraordinary Items 0.75241 0.58946 0.81365 1.14304 1.37895
    Dividends per Share - Common Stock Primary Issue 0.51 0.47 0.47 0.47 0.47
    Diluted Normalized EPS 0.76059 0.58946 0.86503 1.14304 1.37895
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 25224 24239 20441 15667 14632
    Cash and Short Term Investments 10170 10249 7148 4140 4086
    Cash & Equivalents 9882 9799 6838 3860 3844
    Short Term Investments 288 450 310 280 242
    Total Receivables, Net 6218 6487 6414 5425 5182
    Accounts Receivable - Trade, Net 6218 6487 6414 5425 5182
    Total Inventory 6173 5157 5012 4316 3796
    Prepaid Expenses 2663 2346 1867 1638 1445
    Other Current Assets, Total 148 123
    Total Assets 74438 75196 72548 67887 67173
    Property/Plant/Equipment, Total - Net 10278 10112 10130 8972 7563
    Property/Plant/Equipment, Total - Gross 21328 20517 19894 17733 15706
    Accumulated Depreciation, Total -11050 -10405 -9764 -8761 -8143
    Goodwill, Net 22799 23231 23744 23195 23254
    Intangibles, Net 10454 12739 14784 17025 18942
    Long Term Investments 766 816 821 883 897
    Other Long Term Assets, Total 4917 4059 2628 2145 1885
    Total Current Liabilities 15489 13105 11907 10863 9012
    Accounts Payable 4607 4408 3946 3252 2975
    Accrued Expenses 7401 6806 6581 5183 4867
    Notes Payable/Short Term Debt 0 0 213 201 200
    Current Port. of LT Debt/Capital Leases 2251 754 7 1277 7
    Other Current Liabilities, Total 1230 1137 1160 950 963
    Total Liabilities 37752 39394 39764 36799 36649
    Total Long Term Debt 14522 17296 18527 16115 19359
    Long Term Debt 14522 17296 18527 16115 19359
    Deferred Income Tax 991 1392 1406 1546 2056
    Minority Interest 219 222 219 213 198
    Other Liabilities, Total 6531 7379 7705 8062 6024
    Total Equity 36686 35802 32784 31088 30524
    Common Stock 24709 24470 24145 23853 23512
    Retained Earnings (Accumulated Deficit) 35257 31528 27627 25847 24560
    Treasury Stock - Common -15229 -11822 -10042 -10147 -9962
    Unrealized Gain (Loss) 0 0
    Other Equity, Total -8051 -8374 -8946 -8465 -7586
    Total Liabilities & Shareholders’ Equity 74438 75196 72548 67887 67173
    Total Common Shares Outstanding 1737.8 1764.08 1771.23 1762.5 1755.62
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Total Current Assets 24377 25224 24845 24956 23429
    Cash and Short Term Investments 9532 10170 9907 9290 8158
    Cash & Equivalents 9161 9882 9594 8937 7675
    Short Term Investments 371 288 313 353 483
    Total Receivables, Net 6020 6218 6408 7199 7179
    Accounts Receivable - Trade, Net 6020 6218 6408 7199 7179
    Total Inventory 6673 6173 5734 5899 5691
    Prepaid Expenses 2152 2663 2796 2568 2401
    Total Assets 73794 74438 72801 74202 74007
    Property/Plant/Equipment, Total - Net 9282 9162 8689 8818 8908
    Property/Plant/Equipment, Total - Gross 20605 20212 19306 19458 19521
    Accumulated Depreciation, Total -11323 -11050 -10617 -10640 -10613
    Goodwill, Net 22927 22799 22284 22744 23179
    Intangibles, Net 10006 10454 10850 11592 12225
    Long Term Investments 776 766 764 734 763
    Other Long Term Assets, Total 6426 6033 5369 5358 5503
    Total Current Liabilities 14530 15489 13365 12392 12647
    Accounts Payable 4167 4607 4133 4493 4757
    Accrued Expenses 6856 7401 6901 6715 6724
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 2285 2251 1117 5 4
    Other Current Liabilities, Total 1222 1230 1214 1179 1162
    Total Liabilities 36784 37752 37126 37712 38608
    Total Long Term Debt 14615 14522 15297 16755 17086
    Long Term Debt 14615 14522 15297 16755 17086
    Minority Interest 222 219 209 226 230
    Other Liabilities, Total 7417 7522 8255 8339 8645
    Total Equity 37010 36686 35675 36490 35399
    Common Stock 24488 24709 24560 24429 24304
    Retained Earnings (Accumulated Deficit) 35868 35257 35115 34487 33295
    Treasury Stock - Common -15307 -15229 -14555 -13720 -13726
    Other Equity, Total -8039 -8051 -9445 -8706 -8474
    Total Liabilities & Shareholders’ Equity 73794 74438 72801 74202 74007
    Total Common Shares Outstanding 1738.95 1737.8 1743.57 1751.22 1750.94
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line 6933 7071 4495 3687 2368
    Cash From Operating Activities 9581 10533 7901 6136 6300
    Cash From Operating Activities 1254 1491 1195 1078 1100
    Amortization 2013 2047 2132 1936 2178
    Non-Cash Items 900 695 971 766 802
    Cash Taxes Paid 1864 1941 970 930 740
    Cash Interest Paid 563 544 549 677 845
    Changes in Working Capital -1519 -771 -892 -1331 -148
    Cash From Investing Activities -1740 -2008 -2215 -1815 -1356
    Capital Expenditures -1777 -1885 -2177 -1638 -1394
    Other Investing Cash Flow Items, Total 37 -123 -38 -177 38
    Cash From Financing Activities -7636 -5494 -2779 -4289 -10391
    Financing Cash Flow Items 0 -11 0 0
    Total Cash Dividends Paid -3309 -3202 -2560 -2270 -1974
    Issuance (Retirement) of Stock, Net -3628 -2044 -158 -420 33
    Issuance (Retirement) of Debt, Net -699 -248 -50 -1599 -8450
    Foreign Exchange Effects -122 -70 71 -16 -116
    Net Change in Cash 83 2961 2978 16 -5563
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line 1318 6933 5900 4465 2447
    Cash From Operating Activities 1143 9581 7255 4475 2065
    Cash From Operating Activities 315 1254 943 626 311
    Amortization 491 2013 1517 1019 512
    Non-Cash Items 281 900 570 447 305
    Changes in Working Capital -1262 -1519 -1675 -2082 -1510
    Cash From Investing Activities -462 -1740 -1108 -624 -360
    Capital Expenditures -380 -1777 -1167 -700 -321
    Other Investing Cash Flow Items, Total -82 37 59 76 -39
    Cash From Financing Activities -1410 -7636 -6179 -4636 -3823
    Total Cash Dividends Paid -890 -3309 -2486 -1660 -832
    Issuance (Retirement) of Stock, Net -478 -3628 -2984 -2243 -2248
    Issuance (Retirement) of Debt, Net -42 -699 -709 -733 -743
    Foreign Exchange Effects 8 -122 -173 -77 -6
    Net Change in Cash -721 83 -205 -862 -2124
    Financing Cash Flow Items
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 8.9022 154804032 140826 2023-03-31 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 5.0365 87581226 -1284956 2023-03-31 LOW
    Capital Research Global Investors Investment Advisor 4.3937 76404889 -380473 2023-03-31 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 4.2241 73454220 -1157666 2023-03-31 LOW
    Capital International Investors Investment Advisor 3.2451 56430955 3405170 2023-03-31 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.794 31196788 598164 2023-03-31 LOW
    Wellington Management Company, LLP Investment Advisor/Hedge Fund 1.1973 20820152 6003997 2023-03-31 LOW
    MFS Investment Management Investment Advisor/Hedge Fund 1.1714 20370034 -3516448 2023-03-31 LOW
    Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 0.9919 17248522 765489 2022-12-31 LOW
    Wells Fargo Advisors Research Firm 0.8721 15165569 261719 2023-03-31 LOW
    Morgan Stanley Investment Management Ltd. (UK) Investment Advisor 0.8674 15083595 -202533 2023-03-31 LOW
    BofA Global Research (US) Research Firm 0.821 14276700 229604 2023-03-31 LOW
    Polen Capital Management, LLC Investment Advisor/Hedge Fund 0.8194 14249447 -369295 2023-03-31 LOW
    State Farm Insurance Companies Insurance Company 0.7813 13587118 0 2023-03-31 LOW
    Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.7577 13176421 -145790 2023-03-31 LOW
    Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund 0.7087 12324688 44918 2023-03-31 LOW
    Charles Schwab Investment Management, Inc. Investment Advisor 0.6984 12144038 54953 2023-03-31 LOW
    BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 0.69 11998117 -283807 2023-03-31 LOW
    UBS Asset Management (Americas), Inc. Investment Advisor 0.6618 11509019 8668200 2023-03-31 LOW
    Nuveen LLC Pension Fund 0.6085 10582312 377456 2023-03-31 LOW

    Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

    Capital.com Group

    535K+

    Trader

    87K+

    Klien aktif per bulan

    $113M+

    Volume investasi per bulan

    $64M+

    Penarikan tiap bulan

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results
    Laba/Loss
    Industry: Medical Equipment, Supplies & Distribution (NEC)

    100 Abbott Park Rd
    ABBOTT PARK
    ILLINOIS 60064-3500
    US

    Income Statement

    • Annual
    • Quarterly

    People also watch

    BTC/USD

    25,646.25 Price
    -5.960% 1D Chg, %
    Biaya inap posisi Long -0.0616%
    Biaya inap posisi short 0.0137%
    Waktu biaya inap 21:00 (UTC)
    Spread 60.00

    XRP/USD

    0.51 Price
    -7.220% 1D Chg, %
    Biaya inap posisi Long -0.0753%
    Biaya inap posisi short 0.0069%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.00392

    Gold

    1,961.94 Price
    +0.670% 1D Chg, %
    Biaya inap posisi Long -0.0184%
    Biaya inap posisi short 0.0102%
    Waktu biaya inap 21:00 (UTC)
    Spread 0.30

    US100

    14,559.20 Price
    +0.030% 1D Chg, %
    Biaya inap posisi Long -0.0255%
    Biaya inap posisi short 0.0032%
    Waktu biaya inap 21:00 (UTC)
    Spread 1.8

    Masih mencari broker yang bisa Anda percayai?

    Bergabung dengan 535.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

    1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda